BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 8784457)

  • 1. Synthesis and contractile activities of cyclic thrombin receptor-derived peptide analogues with a Phe-Leu-Leu-Arg motif: importance of the Phe/Arg relative conformation and the primary amino group for activity.
    Matsoukas JM; Panagiotopoulos D; Keramida M; Mavromoustakos T; Yamdagni R; Wu Q; Moore GJ; Saifeddine M; Hollenberg MD
    J Med Chem; 1996 Aug; 39(18):3585-91. PubMed ID: 8784457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and modeling of novel cyclic thrombin receptor-derived peptide analogues of the Ser42-Phe-Leu-Leu-Arg46 motif sequence with fixed conformations of pharmacophoric groups: importance of a Phe/Arg/NH2 cluster for receptor activation and implications in the design of nonpeptide thrombin receptor mimetics.
    Alexopoulos K; Panagiotopoulos D; Mavromoustakos T; Fatseas P; Paredes-Carbajal MC; Mascher D; Mihailescu S; Matsoukas J
    J Med Chem; 2001 Feb; 44(3):328-39. PubMed ID: 11462974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activities.
    Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Roumelioti P; Mavromoustakos T; Mihailescu S; Paredes-Carbajal MC; Mascher D; Matsoukas J
    J Med Chem; 2004 Jun; 47(13):3338-52. PubMed ID: 15189031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the amino- and carboxyl-terminal domains of thrombin receptor-derived polypeptides in biological activity in vascular endothelium and gastric smooth muscle: evidence for receptor subtypes.
    Hollenberg MD; Laniyonu AA; Saifeddine M; Moore GJ
    Mol Pharmacol; 1993 Jun; 43(6):921-30. PubMed ID: 8391118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of NK-1 selective, N-backbone cyclic analogs of the C-terminal hexapeptide of substance P.
    Byk G; Halle D; Zeltser I; Bitan G; Selinger Z; Gilon C
    J Med Chem; 1996 Aug; 39(16):3174-8. PubMed ID: 8759639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrazole analogues of cyclolinopeptide A: synthesis, conformation, and biology.
    Kaczmarek K; Jankowski S; Siemion IZ; Wieczorek Z; Benedetti E; Di Lello P; Isernia C; Saviano M; Zabrocki J
    Biopolymers; 2002 May; 63(6):343-57. PubMed ID: 11920436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of potent thrombin receptor antagonist peptides.
    Bernatowicz MS; Klimas CE; Hartl KS; Peluso M; Allegretto NJ; Seiler SM
    J Med Chem; 1996 Dec; 39(25):4879-87. PubMed ID: 8960546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent cyclic peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion. Discovery of compounds like cyclo(MePhe-Leu-Asp-Val-D-Arg-D-Arg) (ZD7349) compatible with depot formulation.
    Dutta AS; Gormley JJ; Coath M; Hassall L; Hayward CF; Gellert PR; Kittlety RS; Alcock PJ; Ferguson R; Halterman T; Jamieson A; Moors JA; Moores JM; Rees A; Wood LJ; Reilly CF; Haworth D
    J Pept Sci; 2000 Aug; 6(8):398-412. PubMed ID: 10969869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Action of thrombin receptor polypeptide in gastric smooth muscle: identification of a core pentapeptide retaining full thrombin-mimetic intrinsic activity.
    Hollenberg MD; Yang SG; Laniyonu AA; Moore GJ; Saifeddine M
    Mol Pharmacol; 1992 Aug; 42(2):186-91. PubMed ID: 1325029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. For-Met-Lys-Phe-For-Met-Lys-Phe-: a new cyclic analogue of the chemotactic formylpeptides.
    Torrini I; Zecchini GP; Paradisi MP; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Traniello S; Spisani S
    Biopolymers; 1995 Apr; 35(4):347-58. PubMed ID: 7711275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
    Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ
    J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
    Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
    J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aza-amino acid scanning of secondary structure suited for solid-phase peptide synthesis with fmoc chemistry and aza-amino acids with heteroatomic side chains.
    Boeglin D; Lubell WD
    J Comb Chem; 2005; 7(6):864-78. PubMed ID: 16283795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A predictive pharmacophore model of human melanocortin-4 receptor as derived from the solution structures of cyclic peptides.
    Sun H; Greeley DN; Chu XJ; Cheung A; Danho W; Swistok J; Wang Y; Zhao C; Chen L; Fry DC
    Bioorg Med Chem; 2004 May; 12(10):2671-7. PubMed ID: 15110848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of amino acid chirality and the chemical linker on the cell permeation characteristics of cyclic prodrugs of opioid peptides.
    Liederer BM; Fuchs T; Vander Velde D; Siahaan TJ; Borchardt RT
    J Med Chem; 2006 Feb; 49(4):1261-70. PubMed ID: 16480263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
    Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G
    J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of a potent cyclic analogue of the myelin basic protein epitope MBP72-85: importance of the Ala81 carboxyl group and of a cyclic conformation for induction of experimental allergic encephalomyelitis.
    Tselios T; Probert L; Daliani I; Matsoukas E; Troganis A; Gerothanassis IP; Mavromoustakos T; Moore GJ; Matsoukas JM
    J Med Chem; 1999 Apr; 42(7):1170-7. PubMed ID: 10197961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aza-scanning of the potent melanocortin receptor agonist Ac-His-D-Phe-Arg-Trp-NH.
    Boeglin D; Xiang Z; Sorenson NB; Wood MS; Haskell-Luevano C; Lubell WD
    Chem Biol Drug Des; 2006 Apr; 67(4):275-83. PubMed ID: 16629825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides.
    Hollenberg MD; Saifeddine M; al-Ani B; Kawabata A
    Can J Physiol Pharmacol; 1997 Jul; 75(7):832-41. PubMed ID: 9315351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.